Blog
B7-H3: A Promising New Target in Tumor Immunotherapy
B7-H3, also known as CD276, is a member of the B7 family of immune checkpoint molecules that has emerged as a compelling target in tumor immunotherapy. Initially recognized for its role
…
3rd Oct 2024